Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Inhibitex Shares Popped: What You Need to Know
Motley Fool
Friday, December 2, 2011 - 11:21am
tags:
Inhibitex, hepatitis C
Roche Pays $20M To Settle Whistleblower Lawsuit
Pharmalot
Friday, December 2, 2011 - 11:20am
tags:
Roche, whistleblower lawsuits, Rituxan, Medicare, Medicaid
[video] The Next Big Thing In Biotech: Biosante
TheStreet.com
Friday, December 2, 2011 - 11:19am
tags:
BioSante, female sexual dysfunction, LibiGel
PDL BioPharma About To Put More Money In Your Pocket
Forbes
Friday, December 2, 2011 - 11:17am
tags:
PDL Biopharma
Warner Chilcott's petition on bowel drug copies granted
Reuters
Friday, December 2, 2011 - 11:16am
tags:
Warner Chilcott, Asacol, inflammatory bowel disease, generics
Lupin gets U.S. nod for oral antibiotic, shares up
Yahoo/Reuters
Friday, December 2, 2011 - 9:34am
tags:
Lupin, antibiotics, Solodyn, Medicis
Pfizer, Teva Accused in Suit of Keeping Generic Drug Off Market
Bloomberg
Friday, December 2, 2011 - 9:33am
tags:
Pfizer, Teva Pharmaceuticals, Effexor, generics, antidepressants
Drugmakers Go From Abundance To Scarcity
Pharmalot
Friday, December 2, 2011 - 9:32am
tags:
pharma industry
Athersys Shares Poised To Move Higher
Seeking Alpha
Friday, December 2, 2011 - 9:31am
tags:
Athersys, Pfizer, Mesoblast, Cephalon, Geron
Pain Management Stocks: Will This Painful Downturn End Soon?
Seeking Alpha
Thursday, December 1, 2011 - 5:09pm
tags:
pain management, Acura Pharmaceuticals, Cumberland, Durect Corporation, Endo, Horizon Pharma, Pacira, Pain Therapeutics, Zogenix
Something to Watch With Johnson & Johnson
Motley Fool
Thursday, December 1, 2011 - 5:08pm
tags:
JNJ
Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Yahoo/AP
Thursday, December 1, 2011 - 12:56pm
tags:
FDA, orphan drugs, Emergent BioSolutions, leukemia, TRU-016, non-Hodgkin's lymphoma, chronic lymphocytic leukemia
CEO: Roche would consider more money-back deals
Fierce Pharma
Thursday, December 1, 2011 - 12:16pm
tags:
Avastin, Roche, Severin Schwan
Sucampo Pharma - Old Drugs, New Hopes
NASDAQ.com
Thursday, December 1, 2011 - 12:14pm
tags:
Sucampo, Rescula, glaucoma, Amitiza
[video] Spectrum Pharmaceuticals CEO: "We Are Always Looking for the Diamond in the Rough."
TheStreet.com
Thursday, December 1, 2011 - 12:12pm
tags:
Spectrum Pharmaceuticals, Zevalin
Why Large Cap Healthcare Multiples Should Expand
Seeking Alpha
Thursday, December 1, 2011 - 12:10pm
tags:
Abbott Laboratories, Gilead, JNJ, Merck, Medtronic, Medicis, Pfizer
Pfizer, GSK named in Onyx buyout gossip
Fierce Biotech
Thursday, December 1, 2011 - 11:48am
tags:
GSK, Pfizer, M&A, ONYX Pharmaceuticals
Health Care's 5 Worst November Flops
Motley Fool
Thursday, December 1, 2011 - 11:42am
tags:
Vertex, Seattle Genetics, Human Genome Sciences, Mako Surgical, Dendreon
Senators Probe Pfizer Plan To Block Generic Lipitor
Pharmalot
Thursday, December 1, 2011 - 11:28am
tags:
Senate, Pfizer, generics, Lipitor, PBMs
Mylan Sued by Warner Chilcott for Patent Infringement Over Generess FE
Bloomberg
Thursday, December 1, 2011 - 11:27am
tags:
Mylan, Warner Chilcott, patents, Generess FE, birth control pill

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.